Ceska M
Vox Sang. 1981;40(6):395-402. doi: 10.1111/j.1423-0410.1981.tb00727.x.
We examined the binding capacity of radioiodinated protein A ([125I]PA) for several human IgG immunoglobulins. Most of them are commercial preparations used in immunosubstitution therapy. Two experimental approaches were chosen. In the first, the binding of [125I] PA to solidified IgG preparations was studied. In the second approach, the inhibition of [125I] PA binding to a given immunoglobulin by various human immunoglobulin samples was established. Both the binding and inhibition criteria were used to estimate the order of the relative binding capacities of the Fc region in studied IgG preparations. The various commercial gamma-globulin preparations were also compared using single radial immunodiffusion and cross-immunoelectrophoretic techniques.
我们检测了放射性碘化蛋白A([125I]PA)与几种人IgG免疫球蛋白的结合能力。其中大多数是用于免疫替代疗法的商业制剂。我们选择了两种实验方法。第一种方法是研究[125I]PA与固化IgG制剂的结合。第二种方法是确定各种人免疫球蛋白样品对[125I]PA与给定免疫球蛋白结合的抑制作用。结合和抑制标准均用于评估所研究IgG制剂中Fc区相对结合能力的顺序。还使用单向放射免疫扩散和交叉免疫电泳技术对各种商业γ-球蛋白制剂进行了比较。